转化生长因子β在心血管疾病中的研究进展
被引量:3
摘要
细胞因子在调节不同表型细胞增殖、迁移、渗出,以及促进动脉粥样硬化等心血管疾病发展中起着非常关键的作用。
出处
《中国心血管杂志》
2011年第2期155-158,共4页
Chinese Journal of Cardiovascular Medicine
参考文献32
-
1Rodriguez G, Mago N, Rosa F. Role of iuflamrnation in atherogenesis. Invest Clin, 2009, 50: 109-129.
-
2Lebrin F, Deckers M, Bertolino P, et al. TGF-beta receptor function in the endothelium. Cardiovasc Res, 2005, 65: 599- 608.
-
3ltoh F,hoh S, Carvalho RL, et al. Poor vessel formation in embryos from knock-in mice expressing ALK5 with IA5 loop mutation defective in Snmd activation. Lab Invest, 2009, 89:800-810.
-
4Lu Q. Transforming growth factor-betal protects against pulmonary artery endothelial cell apoptosis via ALKS. Am J Physiol Lung Cell Mol Physiol, 2008, 295: L123-133.
-
5Jeon SH, Chae BC, Kim HA, et al. Mechanisms underlying TGF-betal-induced expression of VEGF and Flk-1 in mouse macrophages and their implications for angiogenesis. J Leukoc Biol, 2007, 81: 557-566.
-
6Goumans MJ,Valdimarsdottir G, Itoh S, et al. Activin receptorlike kinase (ALK) 1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling. Mol Cell, 2003, 12: 817-828.
-
7Long L, Crosby A, Yang X, et al. Altered bone morphogenetic protein and transforming growth factor-beta signaling in rat models of pulmonary hypertension: potential for activin receptor-like kinaseo5 inhibition in prevention and progression of disease. Circulation. 2009, 119 : 556-567.
-
8Schwartz EA, Reaven E, Topper JN, et al. Transfomfing growth factor-beta receptors localize to caveolae and regulate endothelial nitric oxide synthase in normal human endothelial cells. Biochem J, 2005, 390(Ptl) : 199-206.
-
9Santibanez JF, Letamendia A, Perez-Barriocanal F, et al. Endoglin increases eNOS expression by modulating Smad2 protein levels and Smad2-dependent TGF-beta signaling. J Cell Physiol, 2007, 210: 456-468.
-
10Grond-Ginsbach C, Pjontek R, Aksay SS, et al. Spontaneous arterial dissection: phenotype and molecular pathogenesis. Cell Mol Life Sci, 2010, 67: 1799-1815.
同被引文献32
-
1罗斌,相磊,江东华,孔小平,张能培,何韵,张斌,阳宇,程灵犀.大鼠急性心肌缺血动物实验模型的改进[J].法医学杂志,2006,22(5):321-323. 被引量:3
-
2孙大业,崔素娟,孙颖.细胞信号转导基础篇[M].4版.北京:科学出版社,2010:235-371.
-
3Schlessinger J. Cell signaling by receptor tyrosine kinases [ J]. Cell, 2000, 103(2) :211 -225.
-
4Mark A, Lemmon I, Joseph S. Cell signaling by receptor tyrosine ki- nases [J]. Ce11,2010,141 (7) :1117 - 1131.
-
5Engelman JA. Targeting PI3 K signalling in cancer: opportunities, chal- lenges and limitations [ J ]. Nat Rev Cancer,2009,9 ( 8 ) :550 - 562.
-
6Kaei N, Masakazu N, Yukie K, et al. Aberrant expression of apopto- sis - related molecules in endometriosis : a possible mechanism under- lying the pathogenesis of endometriosis [ J ]. Reprod Sci, 2011, 18 (3) :206 -218.
-
7Yotova IY, Quan P, Leditznig N, et al. Abnormal activation of Ras/ Raf/MAPK and RhoA/ROCKII signalling pathways in eutopic endom- etrial stromal ce|ls of patients with endometriosis [ J 1. Hum Reprod, 2011,26(4) :885 -897.
-
8Morales JK, Falanga YT, Depcrynski A, et al. Mast cell homeostasis and the JAK - STAT pathway [ J ]. Genes Immun, 2010, I l ( 8 ) : 599 - 608.
-
9Harir N, Boudot C, Friedbichler K, et al. Oncogenic Kit controls ne- oplastic mast cell growth through a Stat5/PI3 - kinase signaling, cas- cade [ J J. Blood,2008,112 (6) : 2463 - 2473.
-
10Pedersen M, Ronnstrand L, Sun J. The c - Kit/D816V mutation elimi- nates the differences in signal transduction and biological responses be- tween two isoforms of c -Kit [ Jl. Cell Signal,2009,21 (3) :413 -418.
引证文献3
-
1张铃.酶活性受体及相关信号通路的基础研究[J].医学研究杂志,2012,41(10):16-20.
-
2陈北冬,王文东,赵革新,马丽娜,刘雪青,齐若梅.硫氧还蛋白通过Smad3/AP-1通路抑制人血管内皮细胞黏附蛋白的表达[J].中华老年医学杂志,2013,32(5):469-472. 被引量:1
-
3李子玉,卢国玲,王鑫焱,徐京育.复方丹参饮对急性心肌缺血大鼠心肌组织转化生长因子β_1的影响[J].中医药学报,2013,41(3):90-92. 被引量:4
二级引证文献5
-
1沈炳香,王桐生,魏庆红,李莉,吴金爽,余贵媛,吴德玲.亳菊总黄酮对大鼠急性心肌缺血的保护作用[J].安徽中医药大学学报,2014,33(1):56-59. 被引量:4
-
2钟慧群,赵芸芸,张文风.益气和血通络方对大鼠实验性心肌缺血氧化应激反应的影响[J].中医药信息,2014,31(5):12-13. 被引量:1
-
3谢香荣,李双农,武圣洁.老年人血清硫氧还蛋白和3-硝基酪氨酸与糖尿病视网膜病变相关性研究[J].中华老年医学杂志,2014,33(12):1307-1310. 被引量:1
-
4李诗畅,张慧,于莹,李凤金,牛雯颖,毕悦,肖洪彬.丹参饮药理研究及临床应用研究进展[J].中医药信息,2017,34(5):117-120. 被引量:39
-
5范辉,马骏,韩轶.复方丹参饮对急性心力衰竭大鼠生化指标及细胞生长因子的影响[J].中国老年学杂志,2017,37(21):5220-5221. 被引量:2
-
1郭改娥,张悦红.血清脂蛋白(a)水平与高脂血症表型之间的关系[J].长治医学院学报,1998,12(2):92-95.
-
2陈凯,翟秀梅,郑丽.不同剂量舒利迭对不同表型重度稳定期COPD的临床疗效研究[J].中国现代医生,2011,49(36):158-160. 被引量:1
-
3刘小如,邓泽元,苏海,卢玲,范亚苇,赵文红,张佳.不同表型高脂血症血脂指标相关性[J].中国公共卫生,2010,26(3):307-309. 被引量:1
-
4邵杉,胡司淦,卢冬雨,王洪巨,高大胜,王本芳,蔡鑫.TNF-α和IL-6水平与不同类型冠心病的相关性研究[J].中华全科医学,2011,9(9):1355-1356. 被引量:7
-
5李继琼.噻托溴铵对不同表型慢性阻塞性肺疾病患者的疗效观察[J].华西医学,2013,28(2):172-174. 被引量:1
-
6汤军华,赵德军,张晓燕,沈毅弘.布地奈德/福莫特罗与噻托溴铵吸入治疗对不同表型重度稳定期慢性阻塞性肺疾病患者的临床对比研究[J].中华危重症医学杂志(电子版),2016,9(4):268-270. 被引量:6
-
7窦钊,孙增涛.不同表型慢阻肺患者在“冬病夏治”穴位贴敷法中的疗效差异[J].辽宁中医杂志,2015,42(3):581-582. 被引量:10
-
8方思月,王剑.COPD的HRCT表现型分型及其分析[J].中国CT和MRI杂志,2014,12(7):52-56. 被引量:8
-
9董昭兴,曹宇,濮进敏,张涛,柴燕玲,杨燕妮.HRCT划分慢性阻塞性肺疾病不同表型的临床特征观察[J].昆明医科大学学报,2014,35(11):51-55. 被引量:4
-
10刘国梁.慢性阻塞性肺疾病与支气管哮喘不能合并诊断[J].中华结核和呼吸杂志,2012,35(4):299-300. 被引量:2